anti nrf2 (Proteintech)
Structured Review
![( A ) Overview of cytosolic formaldehyde (FA) catabolism. ( B ) Heatmap depicting Log10 of the 50% FA inhibitory concentration (IC 50 ) in the presence or absence of l -buthionine-sulfoximine (BSO) at concentrations of 25 μM (H2170 cells), 50 μM (Jurkat, Nalm6, K562, and LUDLU-1 cells) or 100 μM (HCT116, H1299, A549, and T98G cells). ( C ) Representative FA viability curves normalized (norm.) to 0 μM FA for H1299 and A549 cells [mean ± SEM, n = 5 (H1299), n = 6 (A549), and two-way ANOVA (Tukey test between untreated (UT) and 100 μM BSO); for H1299: ** P = 0.0016, **** P < 0.0001, and ** P = 0.0023]. ( D ) Glutathione (GSH) levels upon 24-hour exposure to BSO [same concentrations as (B)] (mean ± SEM, n represented as dots, t test comparison between UT and BSO; * P = 0.0142, ** P = 0.0073, **** P < 0.0001). ( E ) Colony survival assay (CSA) in HCT116, H1299, and A549 in the presence of FA and/or 3.12 μM BSO for H1299 cells and 6.25 μM BSO for both HCT116 and A549 cells [mean ± SEM, n represented as dots, one-way ANOVA (Tukey test); for HCT116: **** P < 0.0001; for H1299: * P = 0.0106 and ** P = 0.0033]. ( F ) Left: GSH quantification in A549 cells expressing a nontargeting-control sgRNA (sgNTC) or sgRNAs against GSS (sg GSS ). Right: Viability in response to FA [mean ± SEM, n = 3]. ( G ) Immunoblots in A549 cells carrying an empty vector (pEV) or a vector coding for wild-type KEAP1 (p KEAP1 ). ( H ) Viability curves for A549/pEV or A549/pKEAP1 cells exposed to different concentrations of FA in the presence of 100 μM BSO [mean ± SEM, n = 3 and two-way ANOVA (Tukey test between UT and 100 μM BSO); **** P < 0.0001]. ( I ) DNA-protein cross-link (DPC) accumulation in A549/pEV and A549/pKEAP1 cells exposed to 100 μM BSO for 48 hours and to the indicated concentrations of FA for 4 hours (mean ± SEM, n = 3, one-way ANOVA in each cell line corrected by Tukey test) . Created in BioRender. https://BioRender.com/tsuwhsf .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3651/pmc13693651/pmc13693651__sciadv.aea1431-f1.jpg)
Anti Nrf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 2160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nfe2l2+nrf2/NRF2%2C+NFE2L2+Antibody/pmc13693651-194-80-81
Average 96 stars, based on 2160 article reviews
Images
1) Product Images from "NRF2 coordinates cystine import and glutathione use to sustain ferroptosis resistance and formaldehyde tolerance in cancer"
Article Title: NRF2 coordinates cystine import and glutathione use to sustain ferroptosis resistance and formaldehyde tolerance in cancer
Journal: Science Advances
doi: 10.1126/sciadv.aea1431
Figure Legend Snippet: ( A ) Overview of cytosolic formaldehyde (FA) catabolism. ( B ) Heatmap depicting Log10 of the 50% FA inhibitory concentration (IC 50 ) in the presence or absence of l -buthionine-sulfoximine (BSO) at concentrations of 25 μM (H2170 cells), 50 μM (Jurkat, Nalm6, K562, and LUDLU-1 cells) or 100 μM (HCT116, H1299, A549, and T98G cells). ( C ) Representative FA viability curves normalized (norm.) to 0 μM FA for H1299 and A549 cells [mean ± SEM, n = 5 (H1299), n = 6 (A549), and two-way ANOVA (Tukey test between untreated (UT) and 100 μM BSO); for H1299: ** P = 0.0016, **** P < 0.0001, and ** P = 0.0023]. ( D ) Glutathione (GSH) levels upon 24-hour exposure to BSO [same concentrations as (B)] (mean ± SEM, n represented as dots, t test comparison between UT and BSO; * P = 0.0142, ** P = 0.0073, **** P < 0.0001). ( E ) Colony survival assay (CSA) in HCT116, H1299, and A549 in the presence of FA and/or 3.12 μM BSO for H1299 cells and 6.25 μM BSO for both HCT116 and A549 cells [mean ± SEM, n represented as dots, one-way ANOVA (Tukey test); for HCT116: **** P < 0.0001; for H1299: * P = 0.0106 and ** P = 0.0033]. ( F ) Left: GSH quantification in A549 cells expressing a nontargeting-control sgRNA (sgNTC) or sgRNAs against GSS (sg GSS ). Right: Viability in response to FA [mean ± SEM, n = 3]. ( G ) Immunoblots in A549 cells carrying an empty vector (pEV) or a vector coding for wild-type KEAP1 (p KEAP1 ). ( H ) Viability curves for A549/pEV or A549/pKEAP1 cells exposed to different concentrations of FA in the presence of 100 μM BSO [mean ± SEM, n = 3 and two-way ANOVA (Tukey test between UT and 100 μM BSO); **** P < 0.0001]. ( I ) DNA-protein cross-link (DPC) accumulation in A549/pEV and A549/pKEAP1 cells exposed to 100 μM BSO for 48 hours and to the indicated concentrations of FA for 4 hours (mean ± SEM, n = 3, one-way ANOVA in each cell line corrected by Tukey test) . Created in BioRender. https://BioRender.com/tsuwhsf .
Techniques Used: Concentration Assay, Comparison, Clonogenic Cell Survival Assay, Expressing, Control, Western Blot, Plasmid Preparation
Related Articles
other:Article Title: Investigating the potential risk of cadmium exposure on seizure severity and anxiety-like behaviors through the ferroptosis pathway in epileptic mice: An integrated multi-omics approach. Article Snippet: • Cadmium exposure may induce neuronal ferroptosis and pose a risk to Article Title: Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11 Article Snippet: Article Title: WDR23 mediates NRF2 proteostasis and cytoprotective capacity in the hippocampus Article Snippet: Antibodies used include: Article Title: Effects of chronic low-level lead (Pb) exposure on cognitive function and hippocampal neuronal ferroptosis: An integrative approach using bioinformatics analysis, machine learning, and experimental validation. Article Snippet: • Chronic low-level lead exposure may alter gene expression in lead acid bat- |